Chang YC - Search Results

1

Exploring the Effectiveness of Biological Therapy in Patients with Psoriasis: Body Image and Quality of Life.

Wu CL, Chang YC, Yao WT, Chiang TI. Wu CL, et al. Among authors: chang yc. Medicina (Kaunas). 2024 Jan 15;60(1):160. doi: 10.3390/medicina60010160. Medicina (Kaunas). 2024. PMID: 38256420 Free PMC article.

2

Lack of association between the genetic variations in the C-reactive protein gene and the risk of psoriasis among the Taiwanese.

Chang YC, Wu WM, Hsu LA. Chang YC, et al. Mol Biol Rep. 2012 Apr;39(4):4111-7. doi: 10.1007/s11033-011-1193-4. Epub 2011 Jul 20. Mol Biol Rep. 2012. PMID: 21773944

3

Microsatellite polymorphism in the heme oxygenase-1 gene promoter and the risk of psoriasis in Taiwanese.

Chang YC, Wu WM, Tsai HY, Hsu LA. Chang YC, et al. Arch Dermatol Res. 2012 Nov;304(9):739-44. doi: 10.1007/s00403-012-1289-2. Epub 2012 Sep 11. Arch Dermatol Res. 2012. PMID: 22965812

4

Impact of ABCG2 Gene Polymorphism on the Predisposition to Psoriasis.

Huang YH, See LC, Chang YC, Chung WH, Chang LC, Yang SF, Su SC. Huang YH, et al. Among authors: chang yc, chang lc. Genes (Basel). 2021 Oct 12;12(10):1601. doi: 10.3390/genes12101601. Genes (Basel). 2021. PMID: 34680995 Free PMC article.

5

Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment.

Lin YK, Wang CY, Huang YH, Chang YC, Chen CB, Wang CW, Hui RC, Chung WH. Lin YK, et al. Among authors: chang yc. Pharmgenomics Pers Med. 2022 May 13;15:515-524. doi: 10.2147/PGPM.S351452. eCollection 2022. Pharmgenomics Pers Med. 2022. PMID: 35592551 Free PMC article.

6

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors.

Huang YH, Chang LC, Chang YC, Chung WH, Yang SF, Su SC. Huang YH, et al. Among authors: chang yc, chang lc. Int J Mol Sci. 2023 Feb 26;24(5):4568. doi: 10.3390/ijms24054568. Int J Mol Sci. 2023. PMID: 36902001 Free PMC article.

7

Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.

Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH. Wang CY, et al. Among authors: chang yc. Int J Mol Sci. 2023 Apr 15;24(8):7329. doi: 10.3390/ijms24087329. Int J Mol Sci. 2023. PMID: 37108492 Free PMC article. Review.

8

The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis.

Lin YK, Wong WR, Chang YC, Chang CJ, Tsay PK, Chang SC, Pang JH. Lin YK, et al. Among authors: chang sc, chang yc, chang cj. Dermatology. 2007;214(2):155-61. doi: 10.1159/000098576. Dermatology. 2007. PMID: 17341866 Clinical Trial.

9

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RC, Chin SW, Huang LF, Lin YY, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Wang CW, et al. Among authors: chang wy, chang yc, chang cj. J Clin Invest. 2018 Mar 1;128(3):985-996. doi: 10.1172/JCI93349. Epub 2018 Feb 5. J Clin Invest. 2018. PMID: 29400697 Free PMC article. Clinical Trial.

10

Host characteristics and dynamics of Staphylococcus aureus colonization in patients with moderate-to-severe psoriasis before and after treatment: A prospective cohort study.

Liu SH, Yu HY, Chang YC, Chung-Yee Hui R, Huang YC, Huang YH. Liu SH, et al. Among authors: chang yc. J Am Acad Dermatol. 2019 Aug;81(2):605-607. doi: 10.1016/j.jaad.2018.05.031. Epub 2018 May 25. J Am Acad Dermatol. 2019. PMID: 29803905 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,163 results

Search Page